Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Change in Accured Expenses (2017 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Change in Accured Expenses for 9 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 67.57% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Dec 2025, up 6.69% year-over-year, with the annual reading at $4.6 million for FY2025, 6.69% up from the prior year.
  • Change in Accured Expenses hit $5.4 million in Q4 2025 for Protagonist Therapeutics, down from $7.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $13.0 million in Q3 2021 to a low of -$14.5 million in Q4 2021.
  • Historically, Change in Accured Expenses has averaged -$478400.0 across 5 years, with a median of $693000.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: crashed 659.29% in 2022 and later surged 353.05% in 2025.
  • Year by year, Change in Accured Expenses stood at -$14.5 million in 2021, then soared by 68.39% to -$4.6 million in 2022, then dropped by 16.35% to -$5.3 million in 2023, then soared by 160.47% to $3.2 million in 2024, then surged by 67.57% to $5.4 million in 2025.
  • Business Quant data shows Change in Accured Expenses for PTGX at $5.4 million in Q4 2025, $7.5 million in Q3 2025, and $3.4 million in Q2 2025.